NCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
Clinical Trials
12 trialsNCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT04197089 2022-08-03
VitDURO
Germans Trias i Pujol Hospital
Phase 4 Completed
NCT00482157 2022-03-03
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
Stanford University
Phase NA Withdrawn
NCT03520231 2021-11-23
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
University Health Network, Toronto
Phase 2 Completed
NCT00079001 2020-05-12
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT03290417 2020-02-18
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT00582582 2019-12-13
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT02064946 2019-04-08
High-dose Vitamin D Supplementation for ADT-induced Side Effects
University of Rochester
Phase NA Completed
NCT00499408 2018-11-21
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00329797 2017-11-29
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00585637 2015-04-01
Vitamin D for Chemoprevention
Dana-Farber Cancer Institute
Phase 1 Completed